Top Markets
#1 PulseChain PulseChain +45.01%
#2 Glidr Glidr +14.18%
#3 Fake World Assets Fake World Assets +9.73%
#4 eCash eCash +7.63%
#5 DeFi Kingdoms DeFi Kingdoms +7.52%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.09%
#7 OPENLOOT OPENLOOT +6.78%
#8 Qkacoin Qkacoin +6.48%
#9 Meteora Meteora +5.79%
#10 Bitcoin SV Bitcoin SV +5.63%
Coin of the day
PulseChain PulseChain
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
MYUNGMOON Pharm co.,Ltd MYUNGMOON Pharm co.,Ltd

MYUNGMOON Pharm co.,Ltd

017180
Xếp hạng trong cổ phiếu #28117
MYUNGMOON Pharm Co., Ltd. operates as a pharmaceutical enterprise,... MYUNGMOON Pharm Co., Ltd. operates as a pharmaceutical enterprise, comprehensively handling the research, development, production, distribution, and commercialization of medicinal products. Its business activities extend across South Korea and into global markets. The company offers an extensive array of prescription drugs, addressing a broad spectrum of medical conditions. This range includes treatments for musculoskeletal issues like osteoarthritis, inflammation, rheumatoid arthritis, and muscle relaxation, alongside anti-infectives (antibiotics and antifungals), respiratory aids, and gastrointestinal therapeutics. Cardiovascular health is targeted with circulation agents, anti-hypertensive drugs, and antidiabetic medications. Furthermore, their specialized pharmacotherapy solutions cover narcotics, anesthetics, central nervous system agents, female hormone products, osteoporosis treatments, urogenital medications, adrenocortical hormones, oncology drugs, dermal fillers, and anti-obesity agents. Beyond prescription items, MYUNGMOON Pharm also supplies a diverse selection of over-the-counter (OTC) remedies. These encompass medications for nausea, genitourinary concerns, gum disease, liver support, parasitic infections, constipation, oral ailments, diarrhea, and general digestive health. The OTC portfolio further includes cold and flu treatments, calcium supplements, nasal sprays, multi-vitamins, eye nutrition products, eye drops, blood circulation enhancers, and topical preparations such as external skin treatments and localized pain relievers. In addition to its pharmaceutical lines, the firm markets health supplements, quasi-pharmaceuticals, and blended juice beverages. Established in 1983, MYUNGMOON Pharm Co., Ltd. maintains its primary corporate office in Seoul, South Korea.
Giá cổ phiếu
$0.84293068
Vốn hóa thị trường
$28.18M
Thay đổi (1 ngày)
1.92%
Thay đổi (1 năm)
-29.90%
Quốc gia
KR
Giao dịch MYUNGMOON Pharm co.,Ltd (017180)

Danh mục

Healthcare
Lịch sử chia tách cổ phiếu của MYUNGMOON Pharm co.,Ltd (017180)
Cổ phiếu MYUNGMOON Pharm co.,Ltd (mã: 017180) đã trải qua tổng cộng 0 lần chia tách.
Lần chia tách gần nhất diễn ra vào ngày Aug 20, 2026.
Một cổ phiếu 017180 mua trước ngày Aug 20, 2026 hiện tương đương với 0 cổ phiếu 017180.
Danh sách chia tách cổ phiếu
Năm Chia tách Tỷ lệ Tỷ lệ cộng dồn
Không đủ dữ liệu cho ngày được cung cấp.
Chia tách cổ phiếu của các công ty tương tự hoặc đối thủ
Công ty Số lần chia tách cổ phiếu Tỷ lệ cộng dồn Quốc gia
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 0 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 0 -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 0 -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 0 -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5 x119
IN